190 related articles for article (PubMed ID: 12422153)
1. Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure.
Wagoner LE; Craft LL; Zengel P; McGuire N; Rathz DA; Dorn GW; Liggett SB
Am Heart J; 2002 Nov; 144(5):840-6. PubMed ID: 12422153
[TBL] [Abstract][Full Text] [Related]
2. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
[TBL] [Abstract][Full Text] [Related]
3. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy.
Terra SG; Hamilton KK; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hill JA; Aranda JM; Yarandi HN; Johnson JA
Pharmacogenet Genomics; 2005 Apr; 15(4):227-34. PubMed ID: 15864115
[TBL] [Abstract][Full Text] [Related]
4. Association of Genetic Polymorphisms in the Beta-1 Adrenergic Receptor with Recovery of Left Ventricular Ejection Fraction in Patients with Heart Failure.
Luzum JA; English JD; Ahmad US; Sun JW; Canan BD; Sadee W; Kitzmiller JP; Binkley PF
J Cardiovasc Transl Res; 2019 Aug; 12(4):280-289. PubMed ID: 30756358
[TBL] [Abstract][Full Text] [Related]
5. Confirmation of a role for the 389R>G beta-1 adrenoceptor polymorphism on exercise capacity in heart failure.
Sandilands AJ; Parameshwar J; Large S; Brown MJ; O'Shaughnessy KM
Heart; 2005 Dec; 91(12):1613-4. PubMed ID: 16287753
[No Abstract] [Full Text] [Related]
6. The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity.
Bruck H; Leineweber K; Temme T; Weber M; Heusch G; Philipp T; Brodde OE
J Am Coll Cardiol; 2005 Dec; 46(11):2111-5. PubMed ID: 16325050
[TBL] [Abstract][Full Text] [Related]
7. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
[TBL] [Abstract][Full Text] [Related]
8. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
[TBL] [Abstract][Full Text] [Related]
9. Association between Beta1 -Adrenergic Receptor Polymorphism and Risk of ICD Shock in Heart Failure Patients.
Zanolla L; Guarise P; Tomasi L; Vassanelli C; Cicorella N; Zanini R; Guarrera S; Fiorito G; Matullo G
Pacing Clin Electrophysiol; 2016 Jun; 39(6):557-64. PubMed ID: 27027728
[TBL] [Abstract][Full Text] [Related]
10. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
[TBL] [Abstract][Full Text] [Related]
11. The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure.
Liggett SB; Wagoner LE; Craft LL; Hornung RW; Hoit BD; McIntosh TC; Walsh RA
J Clin Invest; 1998 Oct; 102(8):1534-9. PubMed ID: 9788966
[TBL] [Abstract][Full Text] [Related]
12. Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study.
Lee HY; Chung WJ; Jeon HK; Seo HS; Choi DJ; Jeon ES; Kim JJ; Shin JH; Kang SM; Lim SC; Baek SH
Korean J Intern Med; 2016 Mar; 31(2):277-87. PubMed ID: 26879662
[TBL] [Abstract][Full Text] [Related]
13. The influence of diastolic and systolic function on exercise performance in heart failure due to dilated cardiomyopathy or ischemic heart disease.
Pepi M; Agostoni P; Marenzi G; Dorai E; Guazzi M; Lauri G; Maltagliati A; Guazzi M
Eur J Heart Fail; 1999 Jun; 1(2):161-7. PubMed ID: 10937926
[TBL] [Abstract][Full Text] [Related]
14. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers.
Schwartz SG; Puckett BJ; Allen RC; Castillo IG; Leffler CT
Ophthalmology; 2005 Dec; 112(12):2131-6. PubMed ID: 16325708
[TBL] [Abstract][Full Text] [Related]
15. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
[TBL] [Abstract][Full Text] [Related]
16. β1 adrenergic receptor polymorphisms and heart failure: a meta-analysis on susceptibility, response to β-blocker therapy and prognosis.
Liu WN; Fu KL; Gao HY; Shang YY; Wang ZH; Jiang GH; Zhang Y; Zhang W; Zhong M
PLoS One; 2012; 7(7):e37659. PubMed ID: 22815685
[TBL] [Abstract][Full Text] [Related]
17. GNAS A-1121G variant is associated with improved diastolic dysfunction in response to exercise training in heart failure patients.
Alves AJ; Goldhammer E; Ribeiro F; Eynon N; Ben-Zaken Cohen S; Duarte JA; Viana JL; Sagiv M; Oliveira J
Int J Sports Med; 2013 Mar; 34(3):274-80. PubMed ID: 23065660
[TBL] [Abstract][Full Text] [Related]
18. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
[TBL] [Abstract][Full Text] [Related]
19. The CAREGENE study: polymorphisms of the beta1-adrenoceptor gene and aerobic power in coronary artery disease.
Defoor J; Martens K; Zielinska D; Matthijs G; Van Nerum H; Schepers D; Fagard R; Vanhees L
Eur Heart J; 2006 Apr; 27(7):808-16. PubMed ID: 16421173
[TBL] [Abstract][Full Text] [Related]
20. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
